Viking Therapeutics may offer investors a cheap entry to the weight-loss drug craze
Stock is trading at $28 compared with Eli Lilly’s $739 price tag. That could change if a trial of a pill version of its GLP-1 drug proves effective.
Stay updated with breaking news from Analyst Comment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stock is trading at $28 compared with Eli Lilly’s $739 price tag. That could change if a trial of a pill version of its GLP-1 drug proves effective.
After a decade of seemingly never-ending fee-cutting wars, ETF issuers raised their fees in 2023 as the landscape evolved beyond cheap index-tracking funds.
Signs of weakness are evident but are having little impact so far.
How a top fund manager succeeds, finding ‘underdog’ and other value stocks, and more in MarketWatch’s Mutual Funds Weekly.
New York Community Bancorp Inc. tried to reassure investors Wednesday, saying total deposits have increased in the last several weeks and that it had “ample”...